Hepatic cryptococcosis in a heart transplant recipient.

Transpl Infect Dis

Unit of Infectious & Transplant Medicine, Monaldi Hospital, Second University of Naples, Via Cotugno 1, 80131 Naples, Italy.

Published: March 2004

Cryptococcosis primarily occurs in patients with impaired immune response. While pulmonary and/or cerebral involvement are more often described, there is limited experience of its presence in other sites. We present a case of hepatic cryptococcosis with possible pulmonary involvement in a 54-year-old male heart transplant recipient. Two months after heart transplantation, he developed a persistent, moderate dyspnea with fever and signs of liver damage. Diagnosis was made with liver biopsy for a concurrent reactivation of chronic hepatitis B virus (HBV) infection already present before transplant. Along with a mild chronic HBV hepatitis with fibrosis, we observed sinusoidal dilation and groups of bright, rounded, colorless cells with a central nucleus suggestive of cryptococci. Periodic acid-Schiff stain clearly showed encapsulated yeasts, which supported the diagnosis. Cryptococcal antigen was positive in serum and negative in the cerebrospinal fluid. Computed tomography scan of the chest demonstrated a mild interstitial infiltrate. The patient promptly responded to reduction of immunosuppressive therapy and antifungal treatment with amphotericin B lipid complex and flucytosine followed by maintenance treatment with fluconazole. Cryptococcosis should always be considered in the differential diagnosis in immunocompromised hosts with dyspnea and signs of extrapulmonary involvement. Diagnosis of extrapulmonary and extraneural cryptococcosis is difficult and often fortuitous; a histopathological examination of tissues involved is probably warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-3062.2004.00041.xDOI Listing

Publication Analysis

Top Keywords

hepatic cryptococcosis
8
heart transplant
8
transplant recipient
8
cryptococcosis heart
4
cryptococcosis
4
recipient cryptococcosis
4
cryptococcosis occurs
4
occurs patients
4
patients impaired
4
impaired immune
4

Similar Publications

Disseminated cryptococcosis in a child with liver transplantation: a case report.

Turk J Pediatr

October 2024

Division of Gastroenterology, Hepatology and Nutrition Disease, Department of Pediatrics, Medical School of Ege University, İzmir, Türkiye.

Background: Cryptococcus neoformans causes cryptococcosis, primarily affecting immunocompromised individuals, including solid-organ transplant recipients, and, less frequently, immunocompetent people.

Case: A 15-year-old male with congenital hepatic fibrosis, portal hypertension, and cirrhosis underwent orthotopic liver transplantation. He received perioperative antimicrobial and antifungal prophylaxis and continued immunosuppressive treatment.

View Article and Find Full Text PDF

Cryptococcal Osteomyelitis of the Patella: A Case Report.

JBJS Case Connect

July 2024

Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch, Galveston, Texas.

Case: A 38-year-old woman presented to our clinic with right knee pain and difficulty ambulating. After cultures were obtained, a cryptococcal infection of the patella was identified. Subsequent workup revealed previously undiagnosed HIV/AIDS and a disseminated cryptococcal infection.

View Article and Find Full Text PDF

Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.

Int J Infect Dis

July 2024

Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), c. Casanova, 143, 08036 Barcelona, Spain.; CIBER Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain. Electronic address:

Article Synopsis
  • The study evaluated the safety and effectiveness of isavuconazole in treating non-neutropenic patients with invasive fungal infections (IFIs) across 12 university hospitals from 2018 to 2022.
  • A total of 238 cases were analyzed, with aspergillosis being the most common infection, and only 5.9% of patients experienced toxic effects, mostly related to liver issues.
  • The treatment showed a successful clinical response in about 50.5% of patients after 12 weeks, indicating isavuconazole is a viable option for this patient group.
View Article and Find Full Text PDF

Pulmonary Cryptococcosis: Intense Uptake on Both 18 F-FDG and 68 Ga-FAPI PET/CT.

Clin Nucl Med

November 2023

Department of Nuclear Medicine, XinQiao Hospital, Army Medical University, Chongqing, China.

A 57-year-old woman without hepatitis B or immunodeficiency presented with right upper abdominal pain and cough for 3 months. CT revealed one nodule in the lung and another in the liver. Both 18 F-FDG and 68 Ga-FAPI PET/CT showed increased tracer uptake in these 2 nodules, suggesting pulmonary carcinoma with hepatic metastasis.

View Article and Find Full Text PDF

Rare Hepatic Cryptococcosis Mimicked Metastatic Liver Cancer and Confirmed by Metagenomic Next-Generation Sequencing in an Immunocompetent Patient: A Case Report.

Infect Drug Resist

September 2022

Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, People's Republic of China.

Background: ( is commonly presented in immunocompromised individuals and causes cryptococcosis mostly in the respiratory and/or central nervous system. Liver cryptococcosis is exceedingly rare and sometimes difficult to diagnose through conventional assays.

Case Presentation: The present study reports a rare case of liver cryptococcosis characterized by increased serum carbohydrate antigen 19-9 (CA19-9) level and intrahepatic multiple nodules without other symptoms in an immunocompetent woman.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!